U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07485569) titled 'Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial' on July 18, 2023.
Brief Summary: Rationale Patients with advanced thyroid cancer often have very few treatment options, and standard therapies usually cannot cure the disease. Some types grow and spread quickly and do not respond to surgery and radioactive iodine. For patients with other types, existing drugs may slow the disease but can cause strong side effects, limiting their usefulness. This study is testing a new personalized approach that uses genetic tumor information to identify combinations of existing approved drugs that may work better together. The idea is that...